Doximity Inc header image

Doximity Inc

DOCS

Equity

ISIN null / Valor 111921599

New York Stock Exchange, Inc (2025-12-19)
USD 43.65+0.37%

Doximity Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Doximity Inc is a health tech company founded by industry veterans with backgrounds in institutions like Cleveland Clinic and Stanford University. Led by CEO Jeff Tangney, who previously founded Epocrates, and co-founder Dr. Nate Gross, who previously founded Rock Health, the company is supported by a team of experts and investors in the healthcare industry. With a focus on connecting healthcare professionals and providing digital health solutions, Doximity Inc aims to revolutionize the way medical professionals collaborate and access information.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (16.11.2025):

Doximity Inc’s report for the fourth quarter and fiscal year 2025 shows robust financial growth and improved profitability. In Q4 of fiscal 2025, the company achieved a 17% increase in total revenues to $138.3 million, alongside significant improvements in operating and free cash flows. Over the full fiscal year 2025, Doximity continued its strong performance with a 20% uplift in total revenues to $570.4 million, driven by solid subscription revenue and enhanced operating margins.

Q4 Revenue Growth

In Q4 fiscal 2025, Doximity Inc reported total revenues of $138.3 million, marking a 17% increase year-over-year, with subscription revenue also rising by 17% to $131.9 million.

Improved Profitability

The quarter’s net income climbed to $62.5 million, achieving a margin of 45.2% compared to 34.4% in the prior year, while non-GAAP net income improved to $77.7 million, reflecting enhanced profit performance.

Enhanced Cash Flow Metrics

Q4 operating cash flow surged by 54% to $98.5 million, and free cash flow increased by 56% to $97.0 million, underscoring strong operational cash generation.

Fiscal Year 2025 Strength

For the full fiscal year ended March 31, 2025, total revenues reached $570.4 million—a 20% year-over-year increase—with net income and adjusted EBITDA margins showing significant improvements, reinforcing Doximity’s ongoing growth trajectory.

Future Outlook

Doximity Inc’s guidance for fiscal Q1 2025 anticipates revenues between $139 million and $140 million, with continued optimism for fiscal year 2026 as the company projects revenues between $619 million and $631 million and commensurate adjusted EBITDA growth.

Summarized from source with an LLMView Source

Key figures

-20.9%1Y
29.3%3Y
%5Y

Performance

57.7%1Y
56.3%3Y
67.3%5Y

Volatility

Market cap

5996 M

Market cap (USD)

Daily traded volume (Shares)

3,805,741

Daily traded volume (Shares)

1 day high/low

56.8 / 53.36

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Syzygy AG
Syzygy AG Syzygy AG Valor: 1127753
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.27%EUR 1.55
Kontron AG
Kontron AG Kontron AG Valor: 10395864
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.35%EUR 22.66
Biotest AG
Biotest AG Biotest AG Valor: 325670
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.63%EUR 31.40
Exelixis Inc
Exelixis Inc Exelixis Inc Valor: 1069927
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.06%USD 44.30
Five9 Inc
Five9 Inc Five9 Inc Valor: 23875956
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.24%USD 20.54
Natera Inc
Natera Inc Natera Inc Valor: 28447012
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.21%USD 231.96
Arendals Fossekompani ASA
Arendals Fossekompani ASA Arendals Fossekompani ASA Valor: 599143
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.50%NOK 135.00
REN - Redes Energeticas Nacionais SGPS, SA
REN - Redes Energeticas Nacionais SGPS, SA REN - Redes Energeticas Nacionais SGPS, SA Valor: 3219586
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.87%EUR 3.21
Parsons Corporation
Parsons Corporation Parsons Corporation Valor: 47481760
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.37%USD 61.38
LPKF Laser & Electronics SE
LPKF Laser & Electronics SE LPKF Laser & Electronics SE Valor: 967495
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.90%EUR 5.35